Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib with Docetaxel in Metastatic Breast Cancer
NCT00076024Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of axitinib in breast cancer, sponsored by Pfizer. Started Feb 2004; status: completed.
02
Drugs
axitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00076024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076024.